2025 |
Cutera Inc
|
Director |
- |
- |
2024 |
NovoCure Ltd
|
Independent Director |
- |
- |
2024 |
SI-BONE Inc
|
Independent Director |
- |
- |
2024 |
Cutera Inc
|
Director |
- |
- |
2024 |
Minerva Neurosciences Inc
|
Independent Director |
- |
- |
2023 |
NovoCure Ltd
|
Independent Director |
446.1 K |
0.2 % |
2023 |
SI-BONE Inc
|
Independent Director |
206.3 K |
18.4 % |
2023 |
Minerva Neurosciences Inc
|
Independent Director |
128.3 K |
131.2 % |
2023 |
Cutera Inc
|
Independent Director |
- |
- |
2022 |
NovoCure Ltd
|
Independent Director |
445.2 K |
7.3 % |
2022 |
SI-BONE Inc
|
Independent Director |
174.3 K |
6.4 % |
2022 |
Minerva Neurosciences Inc
|
Independent Director |
55.5 K |
-35.9 % |
2022 |
Talis Biomedical Corp
|
Independent Director |
26.7 K |
-93.1 % |
2022 |
HilleVax Inc
|
Independent Director |
- |
- |
2022 |
Talis Biomedical Corp
|
Independent Director |
- |
- |
2021 |
NovoCure Ltd
|
Independent Director |
414.8 K |
0.0 % |
2021 |
Talis Biomedical Corp
|
Independent Director |
384.5 K |
- |
2021 |
SI-BONE Inc
|
Independent Director |
163.9 K |
-16.8 % |
2021 |
Minerva Neurosciences Inc
|
Independent Director |
86.6 K |
-3.6 % |
2021 |
HilleVax Inc
|
Independent Director |
- |
- |
2020 |
NovoCure Ltd
|
Independent Director |
414.6 K |
0.1 % |
2020 |
SI-BONE Inc
|
Independent Director |
197.0 K |
-10.0 % |
2020 |
Minerva Neurosciences Inc
|
Independent Director |
89.8 K |
-20.1 % |
2020 |
Talis Biomedical Corp
|
Independent Director |
- |
- |
2019 |
NovoCure Ltd
|
Independent Director |
414.3 K |
-40.9 % |
2019 |
SI-BONE Inc
|
Independent Director |
218.9 K |
- |
2019 |
Minerva Neurosciences Inc
|
Independent Director |
112.4 K |
-53.4 % |
2018 |
NovoCure Ltd
|
Independent Director |
701.1 K |
- |
2018 |
Minerva Neurosciences Inc
|
Independent Director |
241.1 K |
- |